Rapid policy action needed to protect patient access to essential medicines as inflation bites

12 October 2022

PHARMACEUTICAL TECHNOLOGY – Inflation drives pharma manufacturing to focus on sustainability

11 October 2022

Inflation is at an all-time high, opening an opportunity for […]

REUTERS – Europe’s generic drugmakers say they may cut output due to energy bills

28 September 2022

The generic drug industry lobby group Medicines for Europe on […]

Open Medicines for Europe letter ahead of the Energy Council – 27 September 2022

27 September 2022

Medicines for Europe warns strongly against energy rationing for medicines production

20 July 2022

The Supplementary Protection Certificate (SPC) manufacturing waiver becomes operational!

1 July 2022

The off-patent medicines industry is a vital part of the solution for healthcare resilience

30 June 2022

Smart reform of EU pharma and IP legislation key to boosting access to essential medicines

28 June 2022

EPSCO (Health) Council – Open letter from Medicines for Europe Executive Committee to European Health Ministers and responsible European Commissioners on inflation impacting the supply of essential medicines

9 June 2022

Central & Eastern European patients have inequitable access to medicines for life-threatening conditions

25 April 2022